{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-172958","form_type":"8-K","ticker":"SPRY","cik":"0001671858","company_name":"ARS Pharmaceuticals, Inc.","filed_at":"2022-06-13T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.731888+00:00","generated_at":"2026-06-25T02:23:49.365184+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Silverback Therapeutics stockholders elect directors, ratify auditor at 2022 annual meeting","bullets":["Andrew Powell and Peter Thompson were elected Class II directors to serve until 2025 annual meeting.","Ernst & Young LLP was ratified as independent auditor for fiscal year ending Dec 31, 2022 with 99.8% of votes in favor.","Approximately 35.1 million shares were outstanding and entitled to vote as of April 11, 2022 record date."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-172958","json":"https://secwatch.observer/filing/0001193125-22-172958.json","markdown":"https://secwatch.observer/filing/0001193125-22-172958.md","text":"https://secwatch.observer/filing/0001193125-22-172958.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1671858/000119312522172958/0001193125-22-172958-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1671858/000119312522172958/d352185d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T02:23:49.365184+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}